Julia Anna Bielicki is a Senior Researcher in Paediatric Infectious Disease at St George’s University of London and a Consultant in Paediatric Infectious Diseases at the University Children’s Hospital in Basel. Julia trained in paediatrics and infectious diseases at the Evelina Children’s Hospital and St Mary’s Hospital, London, as well as at the University Children’s Hospitals in Zurich and Basel, Switzerland and in 2011 obtained a Master of Public Health degree from the London School of Hygiene and Tropical Medicine. Julia’s particular research interests are in observational and interventional studies that aim to improve antibiotic use for neonates and children in the light of an increasing burden of antimicrobial resistance and the need to conserve antibiotics for future generations. From 2011 to 2014, Julia co-ordinated the Antibiotic Resistance and Prescribing in European Children (ARPEC) Project, which recruited nearly 20’000 children from over 40 countries worldwide. Currently, Julia is a key member of the trial management group for CAP-IT, a large UK-based randomised controlled trial of amoxicillin regimens in the treatment of childhood pneumonia. Building on this, she will be leading a multi-national prospective observational cohort of neonatal sepsis and bloodstream infection as part of a new programme of work focusing on the impact of antimicrobial resistance on management of neonatal infection in lower and middle income countries. The ultimate aim is to carry out research that can be translated into interventions that broadly centre on the theme of antimicrobial stewardship.